Home Overview Press Room Blog Publications For Students about us
Search

Inheritable Genetic Modification : Displaying 190-199 of 424


Interview with George Church: Can Neanderthals Be Brought Back from the Dead?by Philip Bethge and Johann GrolleDer SpiegelJanuary 18th, 2013The English translation of the interview in which George Church of Harvard University explains how genetic technology and synthetic biology might permit the creation of a Neanderthal-like clone that could be gestated by a woman.
"Adventurous Female Human" Needed to Give Birth to NeandertalGenome WebJanuary 17th, 2013Harvard's George Church on recreating Neandertals, engineering humans to live to 120, making people resistant to viruses, and exchanging DNA with other species.
A Rebuttal to Mark Lynasí GMO Reversalby Jason MarkEarth Island JournalJanuary 11th, 2013Organic farmer, writer, and environmental policy advocate delves into Lynas' rationale for turning pro-GMO and finds scientific, environmental, economic, and social reasons not to agree.
Eric Hoffman on a Very Discreet Newcomer: Synthetic Biologyby Eric HoffmanA World of ScienceJanuary 11th, 2013An interview on the dangers of synthetic biology published in UNESCO's Natural Sciences Sector's quarterly journal.
Could Human Enhancement Turn Soldiers Into Weapons That Violate International Law? Yesby Patrick LinThe AtlanticJanuary 4th, 2013New technologies reveal ambiguities and hidden assumptions in international humanitarian law.
UK Government's Enthusiasm for GM Not Matched in Developing Nationsby John VidalThe Guardian January 4th, 2013Across the world, countries are turning their backs on GM crops; perhaps the coalition in the UK could learn something from them.
Biotech's 10 Biggest PR Disasters of 2012GMWatchDecember 31st, 20122012 was the year the lights came up on the biotech industry. Its claims, its tactics and its products all came under scrutiny and some of its biggest PR fairytales bit the dust. Here are some prime examples.
Brave New Cells?by Donna DickensonProject SyndicateDecember 29th, 2012Supporters of mitochondria replacement neglect a crucial factor in the debate: the techniques being developed involve permanent genetic alterations passed on to future generations.
FDA Moves Closer to Approval of GMO Fish, Critics Outragedby Carey GillamReutersDecember 21st, 2012A controversial genetically engineered salmon has moved a step closer to the consumer's dining table after the U.S. Food and Drug Administration said the fish didn't appear likely to pose a threat.
My Concerns About Nature Paper on Genome Transfer for Mitochondrial Diseaseby Paul KnoepflerKnoepfler Lab Stem Cell BlogDecember 20th, 2012Is this paper really a clinically relevant breakthrough for mitochondrial disease worthy of a Nature paper?
Displaying 190-199 of 424  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760